home / stock / mcrb / mcrb news


MCRB News and Press, Seres Therapeutics Inc. From 05/06/25

Stock Information

Company Name: Seres Therapeutics Inc.
Stock Symbol: MCRB
Market: NASDAQ
Website: serestherapeutics.com

Menu

Get MCRB Alerts

News, Short Squeeze, Breakout and More Instantly...

MCRB - Seres Therapeutics Q1 2025 Earnings Preview

2025-05-06 12:08:07 ET More on Seres Therapeutics Seres Therapeutics, Inc. (MCRB) Q4 2024 Earnings Call Transcript Seres Therapeutics, Inc. 2024 Q4 - Results - Earnings Call Presentation Seeking Alpha’s Quant Rating on Seres Therapeutics Historical ear...

MCRB - Seres Therapeutics Presents Data at the 2025 Digestive Disease Week Conference Highlighting the Potential for Live Biotherapeutics to Treat Inflammatory and Immune Diseases

CAMBRIDGE, Mass., April 29, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that it will present three related posters at the upcoming 2025 Digestive Disease Week (DDW) Conference being held May 3-6, 2025, in San Diego...

MCRB - Seres Therapeutics to Announce First Quarter 2025 Financial Results and Business Updates on May 7, 2025

CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will host a conference call and live audio webcast on May 7, 2025 at 8:30 a.m. ET to discuss first quarter 2025 financial re...

MCRB - MCRB announced stock split 1-20

2025-04-22 09:00:54 ET Seres Therapeutics, Inc. (MCRB) announced stock split at a ratio of 1-for-20 on 2025-04-22 ... Full story available on KlickAnalytics.com

MCRB - Seres Therapeutics, Inc. (MCRB) Q4 2024 Earnings Call Transcript

2025-03-13 11:04:29 ET Seres Therapeutics, Inc. (MCRB) Q4 2024 Earnings Conference Call March 13, 2025, 8:30 AM ET Company Participants Carlo Tanzi - Kendall Investor Relations Eric Shaff - President and Chief Executive Officer Lisa von Moltke - Executive Vice Pr...

MCRB - Seres Therapeutics GAAP EPS of -$0.81 misses by $0.69

2025-03-13 07:05:18 ET More on Seres Therapeutics Seeking Alpha’s Quant Rating on Seres Therapeutics Historical earnings data for Seres Therapeutics Financial information for Seres Therapeutics Read the full article on Seeking Alpha For further...

MCRB - Expected US Company Earnings on Thursday, March 13th, 2025

Team Inc. (TISI) is expected to report for quarter end 2024-12-31 Chesswood Group Limited (CHWWQ) is expected to report for Q4 2024 J. W. Mays Inc. (MAYS) is expected to report for Q2 2025 Allakos Inc. (ALLK) is expected to report $-0.17 for Q4 2024 Aurora Mobile Limited (JG) is e...

MCRB - Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed primary efficacy endpoint of reduction in bloodstream infections (BSIs) at day 30 post-HSCT; Company expects to submit draft study protocol to FDA in Q2 2...

MCRB - Here's the major earnings before the open tomorrow

2025-03-12 18:00:47 ET Major earnings expected before the bell on Thursday include: Ballard Power Systems ( BLDP ) Dollar General ( DG ) Futu Holdings ( FUTU ) Village Farms International ( VFF ) Weibo ( WB ) Read the full article on Seeking...

MCRB - Seres Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 13, 2025

CAMBRIDGE, Mass., March 04, 2025 (GLOBE NEWSWIRE) --  Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will host a conference call and live audio webcast on March 13, 2025 at 8:30 a.m. ET to discuss fourth quarter and f...

Previous 10 Next 10